Algae Health Sciences is a subsidiary of BGG, offering natural ingredients for dietary supplements, cosmetics, and food & beverage industries. The company has built a strong reputation with leading supplement brands in Japan, USA, and Europe, emphasizing quality and customer service. With facilities in Tokyo, California, Switzerland, and Beijing, Algae Health Sciences ensures efficient service for its largest markets. Leveraging BGG's expertise, Algae Health Sciences focuses on quality, regulatory, and R&D. Their flagship product, AstaZine® Natural Astaxanthin, sourced from microalgae, has been in production since 2006. Notably, they expanded their Astaxanthin farm in 2013 and launched the world’s first Certified Organic Astaxanthin product in 2016. The company prioritizes strict production standards covering various aspects such as GMP, ISO, GMO-Free, Vegan, and others. With plans for ongoing clinical studies, Algae Health Sciences demonstrates a commitment to innovation and product efficacy. For more information, contact Algae Health Sciences at [email protected].
There is no investment information
No recent news or press coverage available for Algae Health Sciences.